Novel antineoplastic ailanthone derivatives (IIb) represented by the following formula wherein R2 is C5-C18 α, β-unsaturated acyl group and its related compounds are disclosed.
Particularly, some of the above compounds are far more effective than mitomycin C against mouse lymphocytic leucemia p388.
These compound can be synthesized from known ailanthone via important intermediates, triacyloxy ailanthone, represented by the formula:
wherein R, is acyl group.
本研究公开了由下式(其中 R2 为 C5-C18 α、β-不饱和酰基)代表的新型抗肿瘤紫罗兰酮衍
生物(IIb)及其相关化合物。
特别是,上述某些化合物对小鼠淋巴细胞白血病 p388 的疗效远高于
丝裂霉素 C。
这些化合物可以从已知的艾兰通通过重要的中间体合成,三乙氧基艾兰通,由式表示:
其中 R 是酰基。